Skip to content
May 14, 2024

Equity.Guru

Investment information for the new generation

Search

Therapix Biosciences

Sol Global Investments’ (SOL.C) 40.7% owned subsidiary Heavenly Rx, inked a memorandum of understanding (MOU) today to go public using Therapix Biosciences (TRPX.Q) for their reverse takeover. Sol originally…